The orphan nuclear receptor steroidogenic factor-1 (SF-1) plays pivotal roles in the development and function of steroidogenic organs. It transcriptionally regulates an array of factors required for biosynthesis of steroid hormones and is also necessary for the expression of genes in the pituitary and the male reproductive tract. Here we describe the identification of a novel zinc finger protein that modifies the transcriptional potential of SF-1. This factor, which we call Zip67 (zinc finger protein 67 
S TEROIDOGENIC FACTOR-1 (SF-1/AD4BP/NR5A1) is one of the major regulators of endocrine function (1) . Targeted deletion of the gene that encodes SF-1 in mice leads to a severe and complex phenotype with ablation of the structures corresponding to adrenals, gonads, and the ventromedial hypothalamic nucleus (VMH). The phenotype is also associated with dysfunctional gonadotropes and male to female sex reversal of internal and external genitalia (2, 3) . During the last years, human patients with mutations in the SF-1 gene have been described, and interestingly, the phenotype shows that SF-1 is essential for normal adrenal and gonadal development in humans also (4) (5) (6) . SF-1 is expressed throughout the zones of the adrenal cortex and in the steroidogenic cells of the gonads. In these cells SF-1 regulates a number of genes involved in the biosynthesis of steroid hormones, such as the cytochrome P450 steroid hydroxylase genes, the ACTH receptor gene and the gene encoding steroidogenic acute regulatory protein (StAR) (7) (8) (9) (10) (11) . SF-1 is also expressed in Sertoli cells, where it synergizes with Sox9 and WT-1 in the regulation of the Mullerian inhibiting substance (MIS) gene (12, 13) . Outside steroidogenic tissues, SF-1 is expressed in the gonadotropes of the pituitary, the VMH, and the spleen (14) (15) (16) . In the gonadotropes, SF-1 regulates the genes encoding the GnRH receptor and the ␣-and ␤-subunits of the gonadotropins (17) . No definitive target genes for SF-1 have been identified in the VMH or spleen.
Based on its structural and functional characteristics, SF-1 belongs to the nuclear receptor (NR) family of transcription factors (8, (18) (19) (20) . Nuclear receptors contain a characteristic zinc finger DNAbinding domain, an intervening hinge region and a C-terminal ligand-binding domain (LBD) that contains an activation function 2 (AF-2) domain. The AF-2 domain is required for ligand-dependent activation, and binding of ligand is believed to cause conformational changes that make the protein more accessible for interactions with coactivators (21) . Although SF-1 can be activated by oxysterols in certain cellular contexts (22) , a bona fide ligand for SF-1 has still not been identified, and SF-1 is therefore classified under the large subgroup of NRs designated orphan NRs (23) . Nevertheless, similarly to other orphan NRs, SF-1 contains a well con-served AF-2 domain that is involved in transcriptional control and interaction with coregulators. For instance, the coactivators steroid receptor coactivator-1 (SRC-1) (24, 25) , transcription intermediary factor-2/glucocorticoid receptor (GR)-interacting protein 1 (GRIP1) and p/CIP [p300/CREB-binding protein (CBP)/cointegrator-associated protein] (26) all interact with the AF-2 domain of SF-1. In addition, SF-1 interacts with proteins that repress its transcriptional potential. The AF-2 domain is required for interaction with the corepressor RIP140 (27) , whereas other repressors, such as the atypical NR Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia cogenita critical region on the X chromosome, gene 1) (12, 28) , silencing mediator of retinoic acid and thyroid hormone receptor (29) , and the DEAD box protein DP103 (30) appear to require domains N terminal to AF-2 for interactions with SF-1.
Although it is possible that the activity of orphan receptors is regulated through the binding of as yet unidentified ligands, other modes of regulation, such as posttranslational modifications and selective interactions with cofactors, are likely to be decisive. In the case of SF-1, both acetylation and phosphorylation events are known to alter its transcriptional potential. Phosphorylation cascades that are initiated by hormonal regulators of steroidogenesis activate many SF-1 target genes, and considerable attention has therefore been focused at defining how SF-1 is altered by these events. Hammer and co-workers (29) demonstrated that SF-1 is directly phosphorylated by MAPKs at serine 203 in the hinge region and that this enhanced the recruitment of cofactors. Furthermore, it was proposed that phosphorylation of serine 203 mimics the stabilizing effect of ligand on the LBD of SF-1 (31) . Protein kinase A (PKA) has also been implicated in SF-1 function, but SF-1 does not appear to be directly phosphorylated by PKA in vivo (29, 32, 33) . However, a recent study demonstrates that the stability of SF-1 increases in the presence of PKA (33), and furthermore, several studies have pointed to a role for the PKA signaling pathway in SF-1-mediated transactivation (7, 26, (34) (35) (36) . It was also reported that SF-1 is acetylated by GCN5 in vitro and that mutations in the putative acetylated residues decrease the transcriptional capacity of SF-1 (37) . Clearly, therefore, various factors and signaling cascades within the cell can fine-tune the activity of SF-1, apparently in the absence of a specific ligand.
With the aim to unravel novel aspects of how the transcriptional capacity of SF-1 can be modified, we performed a yeast two-hybrid screen to identify proteins that interact with the C-terminal region of SF-1. To this end, we identified a novel protein that is highly conserved between mouse and human and that represses SF-1-dependent transcriptional activity as well as the transcriptional activity of other NRs.
RESULTS

Cloning of Zip67
To identify factors that interact with SF-1, we used the LBD and hinge region of bovine SF-1 (amino acids 107-461) as the bait in a yeast two-hybrid screen of a human testis cDNA library. After repeated selection and retransformation, approximately 50 positive clones were sequenced. Among these was a 763-bp fragment of a hitherto unknown cDNA. Search of the human genome database with this fragment gave perfect match to chromosome 19, and further analyses using the NIX database (38) strongly indicated that the isolated fragment was part of a cDNA encoded by a gene consisting of nine exons located between bp 53,541 and 77,364 on chromosome 19 (Fig. 1A) . The gene computation was strengthened by the prediction of a promoter region containing a TATA box approximately 100 bp upstream of the ATG start codon and a putative poly(A) tail downstream of the last exon. The fragment that was isolated in the two-hybrid screen corresponded to nucleotides 1,134-1,882 of the predicted cDNA (Fig. 1A) . The full-length cDNA was subsequently cloned from a human testis cDNA library by a combinatorial approach of conventional hybridization screening and PCR (Fig. 1B) . We named this novel factor Zip67, for zinc finger protein 67 kDa.
Sequencing of the full-length human Zip67-cDNA revealed a perfect match to the predicted exons of the corresponding region of chromosome 19, and the intervening sequence completely matched the exonintron boundaries by the GT-AG rule (39) (see Table 1 for details). Importantly, the length of the Zip67 cDNA, as predicted from the NIX database, was in agreement with the mRNA size observed on Northern blots (data not shown). Translation of the full-length Zip67 cDNA resulted in a protein product of approximately 67 kDa, consistent with an open reading frame of 615 amino acids (Fig. 1C) . We used the Compute pI/Mw tool from ExPASy (40) to calculate the theoretical molecular mass of the amino acid sequence, and Zip67 was predicted to be 67.234 kDa. Furthermore, an antibody raised against aa 445-458 (AIIYEIPKEPEKRR) in human Zip67 recognized a protein of 67 kDa in extracts prepared from mouse adrenocortical tumor cells (Y1) and COS-1 cells (Fig. 1D) . The Pfam 6.6 protein family database (41) predicted five classic C 2 H 2 zinc fingers in the C terminal of the Zip67 protein (with E values ranging from 2.1 e-7 to 0.005; Fig. 3 ), and the PSORT database (42) predicted two nuclear localization signals located between amino acids 107-118 and 445-451 (Fig. 3) . Apart from these domains, no other protein motifs with significant E values were recognized.
Zip67 Interacts Directly with SF-1 in an AF-2-Dependent Manner
To assert that the interaction between SF-1 and Zip67 was direct and independent of other factors present in yeast, we performed an in vitro protein-protein interaction assay using purified baculovirus-expressed (His) 6 -SF-1 fusion protein and in vitro translated Zip67 protein. When incubated together with (His) 6 -SF-1, radiolabeled Zip67 could be pulled down by nickelchelate-nitrilotriacetic acid (Ni-NTA) agarose, demonstrating a direct interaction between these two proteins ( Fig. 2A) . No interaction was observed with the Ni-NTA agarose alone. The part of SF-1 used in the two-hybrid screen contains the AF-2 domain that is known to be important for interactions with certain cofactors. To investigate the significance of this domain for the interaction with Zip67, we included a mutated form of SF-1 that carries a deletion in the AF-2 domain [(His) 6 -SF-1⌬AF-2] in the experiment. Interestingly, the interaction between Zip67 and SF-1 was nearly abrogated in the absence of a functional AF-2 domain ( Fig. 2A) . A yeast-mating assay confirmed the requirement for the AF-2 domain of SF-1. In these experiments the same region of SF-1 that was used in the initial two-hybrid screen (SF-1 107-461 ), either wild type or a mutant carrying a deletion of the AF-2 domain, was fused to the LexA DNA-binding domain to make up the plasmids LexA/SF-1 and LexA/SF-1 107-461 ⌬AF-2. The cDNA encoding Zip67 (bp 1134-1882; the fragment isolated in the two-hybrid screen) was fused to the B42 transcriptional activation domain (B42/Zip67), and the bait and prey plasmids were transformed into MATa and MAT␣ strains, respectively. A liquid semiquantitative ␤-galactosidase assay demonstrated a 16-fold increase in reporter gene activity when SF-1 and Zip67 were brought together in the diploid cell (Fig. 2B) . Similarly to what we observed in the pulldown assay, the interaction between SF-1 and Zip67 was completely annulled when the AF-2 domain was deleted (Fig. 2B) . Western blot analyses of protein extracts prepared from transformed yeast using an anti-LexA antibody, demonstrated that LexA/SF-1 and LexA/SF-1 107-461 ⌬AF-2 were expressed at equal levels (data not shown) (26) . LexA/SF-1 and B42/Zip67 showed very low or undetectable ␤-galactosidase activity when transformed alone or together with the empty vectors (Fig. 2B ). Together these experiments indicate that the interaction between SF-1 and Zip67 is direct A, The gene encoding Zip67 is located on human chromosome 19 (between bp 52,860 and 75,217) as predicted by the NIX database. The gene, which contains 9 exons, encodes an mRNA of 2101 bp that gives rise to a protein product of 615 amino acids. The protein contains 5 zinc finger domains (u). The position of the 763-bp fragment that was originally iso-and independent of additional factors. Furthermore, although it cannot be excluded that other domains of SF-1 participate in the binding of Zip67, our results clearly point to an absolute requirement for the AF-2 domain.
Cloning of the Mouse Homolog of Zip67
Search of the mouse expressed sequence tag database revealed the presence of fragments with high homology to the human Zip67 cDNA. Based on this information we constructed primers that corresponded to the most 5Ј and 3Ј sequences. Using these primers a fragment of the expected size was amplified from a mouse testis cDNA library, and sequencing revealed that we had isolated the mouse homolog of Zip67. The overall identity between human and murine Zip67 was 85% at the nucleotide level and 90% at the amino acid level (Fig. 3) , demonstrating a high degree of evolutionary conservation and suggesting important physiological roles for this protein.
Expression of Zip67
The expression profile of Zip67 was analyzed in mouse and human tissues. We performed quantitative RT-PCR on mRNA isolated from various mouse tissues. The levels of Zip67 mRNA were measured using a standard curve generated from a linearized plasmid containing the full-length mouse Zip67 cDNA. The values were normalized against the content of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in the same extracts. For both Zip67 and GAPDH the amplification crossed an intron/exon boundary, virtually eliminating the possibilities of chromosomal DNA artifacts. Agarose gel electrophoresis and melting point analyses of the PCR products revealed the presence of a single species in each sample (Fig. 4A ). As shown in Fig. 4B , we identified the highest levels of Zip67 mRNA in the testis. Relatively high levels were also detected in the spleen. In addition, we found moderate levels of expression in lung, adrenal gland, uterus, and ovary, whereas the rest of the tissues examined (i.e. pancreas, heart, skeletal muscle, adipose tissue, kidney, and liver) contained low to undetectable levels. To determine the expression profile of Zip67 in humans, we radiolabeled the human Zip67 cDNA and hybridized it to a Multiple Tissue Expression Array blot (Clontech, Palo Alto, CA). It became evident that in humans, Zip67 is expressed at high levels in the testis (Fig. 5) . Furthermore, we found that Zip67 is abundantly expressed in certain areas of the brain (i.e. cerebellum, temporal lobe, and hippocampus). In addition, relatively high expression was found in the adrenal gland. After extensive washing of the filter, weak hybridization signals were still apparent in some of the negative controls. We therefore used a phosphorimaging system to obtain semiquantitative values of the hybridization signals relative to the negative controls. Such an analysis demonstrated that, similarly to those in the mouse, moderate levels of Zip67 were found in human spleen and uterus. In addition, Zip67 mRNA was apparent in thymus, pancreas, kidney, stomach, and rectum. Although the cellular localization needs to be examined further, it is clear that Zip67 is coexpressed with SF-1 in tissues in which this NR is known to play fundamental physiological roles (i.e. testis and adrenal gland) in both mice and humans. However, it also became evident that the expression patterns of these two factors do not overlap absolutely, as Zip67 does not appear to be present in human ovary, and Zip67 exhibits a broader expression pattern.
Zip67 Represses Transcription Mediated by Nuclear Receptors
To investigate the functional significance of the interaction between SF-1 and Zip67, we examined whether Zip67 could affect the transcription of reporter genes driven by SF-1-dependent promoters. We previously described an element, cAMP-responsive sequence 2 (CRS2), from the bovine cytochrome P450 17␣-hydroxylase gene (CYP17) that is positively regulated by SF-1 (7). A reporter construct containing four copies of CRS2 placed upstream of a minimal thymidine kinase (TK) promoter and luciferase as the reporter gene (4CRS2-luc) was transfected into Y1 mouse adrenocortical cells. Y1 cells express relatively high lev- els of SF-1 endogenously, and luciferase activity can therefore also be detected in the absence of externally added SF-1 (Fig. 6A) . However, the luciferase activity was further increased around 8-fold when SF-1 was coexpressed (Fig. 6A) . Interestingly, when an expression plasmid encoding Zip67 was included in the experiments the luciferase activity decreased in both the presence and absence of overexpressed SF-1. These results clearly indicate, therefore, that Zip67 opposes the effects of SF-1 in vivo.
To examine whether the effect of Zip67 could be reconstituted on an intact SF-1-responsive promoter, a fragment of the bovine CYP17 gene promoter was placed upstream of the reporter gene luciferase (CYP17-290-luc). This fragment, which spans from Ϫ290 to ϩ17 relative to the start site of transcription, contains the CRS2 element described above. Sequence alignment with the human CYP17 gene suggests that another SF-1 binding element may be present around bp Ϫ240 (43); however, the functional significance of this element has not been evaluated in the context of the bovine promoter. When CYP17-290-luc was transfected into Y1 cells together with the expression plasmid encoding SF-1, we observed, as expected, an increase in luciferase activity (Fig. 6B) . The induction was not as profound as for 4CRS2-luc, probably because of the fewer copies of SF-1 binding sites present in this native promoter. Again, coexpression of Zip67 led to decreased luciferase activity, and similarly as for 4CRS2-luc, the repressive effect of Zip67 was found in both the presence and absence of exogenously added SF-1. Similar results were observed when Y1 cells were transfected with the promoter from the cytochrome P450 side-chain cleavage gene (CYP11A). The CYP11AϪ186-luc plasmid contains the region between Ϫ186 and ϩ12 of the bovine CYP11A gene linked to luciferase. This region of the CYP11A promoter is known to contain at least one SF-1-binding site located at Ϫ39/Ϫ48 relative to the start site of transcription and will support SF-1 inducibility in COS-1 cells (data not shown) (44) . In contrast to the CYP17 promoter construct, additional expression of SF-1 did not increase luciferase activity above background levels (Fig. 6C) . Most likely the reason for this is that the endogenous levels of SF-1 in Y1 cells are sufficiently high for full activation of this construct. Analogously to what was observed for CYP17, Zip67 also repressed this natural SF-1-dependent promoter.
To assure that the effect of Zip67 is dependent on SF-1, we used COS-1 cells that do not express endogenous SF-1 and in which 4CRS2-luc shows minimal activity without exogenous addition of SF-1 (7). The 4CRS2-luc construct was transfected into the COS-1 cells together with increasing amounts of Zip67 in the presence or absence of SF-1. As previously shown (7, 26) , the transcriptional activity was induced by coexpression of SF-1 (Fig. 6D) . Coexpression of Zip67 repressed transcriptional activity in presence of SF-1, whereas the effect was minimal in the absence of SF-1. These results thereby suggest that the repressive effect is dependent on SF-1 (Fig. 6D) . Furthermore, SIP67 exerted no effect on transcription mediated by the cytomegalovirus (CMV)-␤-galactosi- ⌬AF-2) fused with the LexA DNA-binding domain. After mating, ␤-galactosidase activities were measured (RLU/OD 600 ). As controls, yeast carrying either LexA/SF-1 or B42/Zip67 were mated with transformants carrying empty prey or bait vectors, respectively (marked Ϫ). In addition, we included a negative control in which B42/Zip67 was combined with LexA/lamin. The figure shows the mean values of at least four independent colonies. dase reporter plasmid, arguing against a general repressive effect (data not shown).
The rather broad expression pattern suggested a role for Zip67 that extends beyond that of being a cofactor exclusively for SF-1. To investigate whether Zip67 would repress transcription mediated by other NRs, we performed transient transfection experiments in COS-1 cells. Reporter constructs carrying binding sites for peroxisomal proliferator-activated receptor ␥ (PPAR␥), liver X receptor (LXR)␣, nerve growth factor inducible clone B (NGFI-B), GR and estrogen receptor (ER) linked to luciferase as the reporter gene were transfected together with expression plasmids encoding the corresponding NR. The cognate ligands were included as indicated in Fig. 7 . Interestingly, coexpression of Zip67 led to a dose-dependent decrease in reporter gene activity for all of the NRs tested, suggesting that Zip67 functions as a general cofactor for this group of transcription factors.
The data presented in Fig. 2 demonstrated an absolute requirement for the AF-2 domain for the interaction between SF-1 and Zip67. To investigate whether Zip67 could inhibit other classes of transcription factors that lack this domain, we examined the effect of Zip67 on transcription mediated by the basic leucine zipper transcription factor cAMP response element-binding protein (CREB) and the helix-loop-helix PAS (Per-Arnt-Sim) domain factors arylhydrocarbon receptor (AhR)/AhR nuclear translocator (Arnt). COS-1 cells were transfected with an expression plasmid encoding CREB (Rous sarcoma virus-CREB) together with a reporter plasmid carrying CREB-binding elements (4CRE-luc). As transcription mediated by CREB is activated by PKA, an expression plasmid encoding the catalytic subunit of PKA (pCMV5-C␣) was included in the experiment (Fig. 8A) . In Fig. 8B , HeLa cells were transfected with a reporter construct carrying xenobiotic response elements (2XRE-luc) and subsequently The mouse and human Zip67 sequences are 85% identical at the nucleotide level and 90% identical at the amino acid level. The five predicted zinc finger regions are shaded, and the putative nuclear localization signals are given in bold. The underlined sequence corresponds to the fragment that was isolated in the initial two-hybrid screen. treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin for 24 h to induce transcription mediated by AhR/Arnt. In these systems we did observe a decrease in luciferase activity when Zip67 was coexpressed. However, compared with NRs (Figs. 6 and 7) , the effect was minor, and furthermore, a similar attenuation in reporter gene activity was found when transcription was driven by the TK promoter alone (i.e. TK-␤-galactosidase; data not shown). This indicates that the effect is independent of CREB and AhR/Arnt and instead is mediated through the TK promoter. Such a minor effect of Zip67 on basal transcription when overexpressed is not surprising, and it was also previously reported that NR coregulators can affect constitutive promoters (45) .
Zip67 Counteracts the Positive Effect of GRIP1 on SF-1-Dependent Transcriptional Activity
To investigate whether Zip67 contains an intrinsic repressive function, we linked the Zip67 cDNA to the GAL4 DNA-binding domain. Surprisingly, as shown in Fig. 9 , we found that this fusion protein slightly activated transcription when expressed together with a reporter plasmid that carries GAL4-binding elements. When a fusion protein between GRIP1 and GAL4 was included in the experiment, it became clear, however, that Zip67 is a weak activator compared with this representative from the p160 family of coactivators. The fact that both p160 coactivators (24) (25) (26) 29) and Zip67 ( Fig. 2) interact with SF-1 through the AF-2 domain led us to hypothesize that the mechanism by which Zip67 represses SF-1-dependent transcription might be through competition for the AF-2 domain. We therefore transfected COS-1 cells with the reporter plasmid 4CRS2-luc together with expression plasmids encoding SF-1, Zip67, and GRIP1. As shown in Fig.  10A , increasing amounts of Zip67 counteracted the positive effect of GRIP1 on SF-1-dependent transcription in a dose-dependent manner, and conversely, GRIP1 opposed the negative effect of Zip67 in this system. To examine whether Zip67 and GRIP1 could compete for SF-1 binding in a more direct mode, we performed an in vitro competition interaction analysis. In this experiment, [ 35 S]methionine-labeled in vitro translated GRIP1 and Zip67 were incubated with a (His) 6 -SF-1 fusion protein, and the protein complexes were pulled down by Ni-NTA agarose. Although the bands in this experiment appeared relatively faint, it can be seen in Fig. 10B (lane 1) that GRIP1 interacts with SF-1 in this system, and furthermore, that the addition of increasing amounts of Zip67 causes a dose-dependent decrease in the binding of GRIP1 and a corresponding increase in the binding of Zip67 to SF-1 (Fig. 10B, lanes 2-4) . Taken together, these results suggest that Zip67, although a weak activator in itself, will act as a general repressor of transcriptional activation by NRs by preventing the interaction with much more potent coactivators, such as GRIP1.
DISCUSSION
In this study we describe the protein Zip67, a novel transcriptional coregulator of SF-1 and other NRs. Zip67 cDNA was isolated through its ability to interact with the LBD domain of SF-1 and encodes a 67-kDa protein containing five C 2 H 2 zinc fingers in its Cterminal region. Several other C 2 H 2 zinc finger proteins were previously described to directly interact with SF-1 and modulate its transcriptional activity (12, (46) (47) (48) . Similarly to Zip67, Sp1 and TReP-132 are known to affect the activity of steroid hydroxylase genes through interactions with SF-1 (i.e. CYP11A and CYP17) (44, 49) . The Egr-1 protein interacts with SF-1 on the LH␤ promoter providing a synergistic effect on transcription and thereby affecting female reproductive capacity (48) , and WT1 associates with SF-1 to promote MIS expression during testis development (12). The above-mentioned factors potentiate the tran- scriptional capacity of SF-1. In contrast, the major role of Zip67 appears to be that of a transcriptional repressor of NRs, at least in cellular contexts where p160 coactivators are not limiting. Electrophoretic mobility shift assays demonstrated that Zip67 is unable to interact directly with the SF-1-binding elements used in the transfection experiments, and moreover, that the binding of SF-1 was unaffected by the presence of Zip67 (data not shown). It appears, therefore, that Zip67 does not require contact with DNA to modulate SF-1-dependent gene activation. Analogous modes of protein-protein interaction between SF-1 and coregulators were previously described to take place on other promoter elements. For instance, the stimulation by WT1 via the SF-1-binding element from the MIS promotor occurs without direct interaction between WT1 and DNA (12) . Similarly, the recruitment of TReP-132 to the human CYP11A1 gene is believed to happen solely through a protein-protein interaction with SF-1 (47) . Furthermore, the homeobox transcription factor Ptx1 synergizes with SF-1 to promote expression of the proopiomelanocortin gene without interacting with DNA (50) . In contrast, the promoters described to be regulated by SF-1 and Sp1 or Egr1 contain adjacent DNA-binding sites that are contacted by the involved factors (44, 46, 51) . The presence of C 2 H 2 zinc fingers in Zip67 suggests that it is able to act as a transcription factor through direct interaction with DNA. It is not unusual that transcription factors can be recruited to promoters by both protein-protein and protein-DNA interactions (12, (52) (53) (54) , and it remains to be determined whether Zip67 recognizes DNA sequences through its zinc finger domains.
The AF-2 domain is highly conserved between the NRs and comprises an amphipathic ␣-helix with the consensus motif XE ( indicates a hydrophobic amino acid, and X is any amino acid). Coactivators of NRs typically contain NR boxes that function as interaction domains. For instance, the p160 family interacts A-C, Expression plasmids encoding SF-1 (pCMV-SF-1; 100 ng) or Zip67 (pCMV-BK-Zip67; 10-500 ng as indicated) were cotransfected with the reporter plasmids 4CRS2-luc (1.5 g; A), CYP17-290-luc (1.5 g; B) , or CYP11A-186-luc (1.5 g; C) into Y1 cells grown on 35-mm dishes by the calcium phosphate precipitation technique. After 24 h, the cells were harvested, and luciferase activities were determined. In all experiments a plasmid encoding ␤-galactosidase was cotransfected to control for transfection efficiencies. The figure shows the mean (ϮSD) luciferase activity (calculated relative to the ␤-galactosidase activity in each corresponding extract) from at least three independent experiments. D, Expression plasmids encoding SF-1 (pCMV-SF-1; 100 ng) or Zip67 (pCMV-BK-Zip67; 100-1000 ng as indicated) were cotransfected with the reporter plasmid 4CRS2-luc (1.5 g) into COS-1 cells. After 48 h, the cells were harvested, and luciferase activities were determined. The figure shows the mean (ϮSD) luciferase activity from at least three independent experiments. (Fig. 2) . Despite effort, we have not been able to map the domain(s) of Zip67 that mediates the contact with SF-1. The peptide sequence of Zip67 indicates the presence of three ␣-helixes that resemble CoRNR boxes interspaced between the five C 2 H 2 zinc fingers in the C-terminal part of the protein. However, mutational analysis suggests that these putative ␣-helixes are not of importance for interaction with SF-1, and it appears, therefore, that Zip67 interacts with the AF-2 domain in a different fashion than most coregulators. Interestingly, the coregulators PNRC and PNRC2 (proline-rich NR coregulator protein) interact with SF-1 and other NRs in an AF-2-dependent manner, but the interaction does not depend on LXXLL motifs, but, instead, on an Src ho-A, Expression vectors encoding PPAR␥ (pcDNA3.1-hPPAR␥; 150 ng) and Zip67 (pBK-CMV-Zip67; 50-1000 ng) were transfected into COS-1 cells as indicated in the figure together with the reporter construct 3PPRE-luc (0.9 g). Twenty-four hours after transfection the cells were treated with 1 M BRL49653. B, The expression vectors encoding LXR␣ (pCMX-LXR␣; 150 ng), RXR␣ (pCMV-RXR␣; 150 ng), and Zip67 (pBK-CMV-Zip67; 50-1000 ng) were transfected into COS-1 cells as indicated in the figure together with the reporter construct LXR␣-luc (1.0 g). Twenty-four hours after transfection, the cells were treated with 20 M 22(R)-hydroxycholesterol. C, Expression plasmids encoding NGFI-B (pCMX-NGFI-B; 100 ng) and Zip67 (pBK-CMV-Zip67; 100-1000 ng) were cotransfected with the reporter plasmid NBRE-luc into COS-1 cells. D, Expression vectors encoding GR (pCMV5-GR; 100 ng) and Zip67 (pBK-CMV-Zip67; 50-1000 ng) were transfected into COS-1 cells as indicated in the figure together with the reporter construct mouse mammary tumor virus-luciferase (1.0 g). Twenty-four hours after transfection, the cells were treated with 0.1 M dexamethasone. E, Expression vectors encoding ER (pSG5-ER␣; 100 ng) and Zip67 (pBK-CMV-Zip67; 10-1000 ng) were transfected into COS-1 cells as indicated in the figure together with the reporter construct estrogen response element-luciferase (1.0 g). Twenty-four hours after transfection, the cells were treated with 0.1 M 17␤-estradiol. Luciferase assays were performed 48 h after transfection. For all experiments the figure shows the mean Ϯ SD of triplicate transfections from representative experiments. (60, 61) . However, Zip67 does not contain such a motif, and we are currently investigating the mechanism by which Zip67 interacts with the AF-2 domain.
The results presented in Fig. 9 indicate that Zip67 contains an intrinsic activation function when linked to GAL4. However, these results further show that in comparison with the p160 coactivators (here exemplified by GRIP1), Zip67 appears to be a very weak activator. Although it is possible that Zip67 acts as an activator under certain physiological conditions, our transient transfection experiments clearly point to a repressive function of Zip67 in a cellular context with biologically relevant amounts of p160 coactivators (Figs. 6 and 7) . These results together with the findings that Zip67 counteracts the positive effect of GRIP1 in transient transfection experiments and that Zip67 and GRIP1 can displace each other from SF-1 (Fig. 10) obviously indicate a mechanism of action in which Zip67 represses SF-1-dependent transcription by hindering the binding of more potent coactivators. The zinc finger protein mZac1b appears to have similar properties, as it also exhibits an activation function when linked to GAL4, whereas it will either activate or repress NR function depending on the cellular context (52). Furthermore, RIP140, which has been demonstrated to interact with several NRs, including SF-1, seems to work in an analogous fashion (27, (62) (63) (64) (65) (66) (67) . RIP140 was also shown to act as a coactivator under certain experimental conditions (68) , but the consensus is that this protein functions as a repressor by influencing the binding of endogenous coactivators as well as through recruitment of histone deacetylases (69) . In transient transfection assays, RIP140 can antagonize SRC-1-mediated activation through competition with the coactivator for binding to the AF-2 domain (70) . RIP140 also counteracts the stimulatory action of p160 coactivators on SF-1-dependet transcription, possibly by the same competition mechanism for binding to the AF-2 domain of SF-1 (27) .
Real-time PCR and dot-blot experiments (Figs. 4  and 5 ) demonstrated that Zip67 exhibits a broad ex- A, Expression vectors encoding CREB (Rous sarcoma virus-CREB; 100 ng), the catalytic subunit C␣ of PKA (pCMV5-C␣; 100 ng), and Zip67 (pBK-CMV-Zip67; 100-500 ng) were transfected into COS-1 cells as indicated in the figure together with the reporter construct 4CRE-luc (1.5 g). Luciferase assays were performed 48 h after transfection. The figure shows the mean Ϯ SD of duplicate transfections from a representative experiment. B, The expression vector encoding Zip67 (pBK-CMV-Zip67; 100-500 ng) were transfected into HeLa cells as indicated in the figure together with the reporter construct 2XRE-luc (0.5 g). Twenty-four hours after transfection the cells were treated with 10 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin. Luciferase assays were performed 48 h after transfection. The figure shows the mean Ϯ SD of triplicate transfections from a representative experiment.
Fig. 9. Zip67 Exhibits a Weak Intrinsic Activation Function
Expression plasmids encoding GAL4 (pBIND or pM; 1.5 g), GAL4-GRIP1 (pM. GRIP1; 1.5 g), or GAL4-Zip67 (pBIND-Zip67; 1.5 g) were cotransfected with the reporter plasmid pSGluc (1.5 g) into Y1 cells. After 24 h, the cells were harvested, and the luciferase activities were determined. The figure shows the mean (ϮSD) luciferase activity from at least three independent experiments. pression pattern, suggesting that it affects many biological systems. In line with this, we found that Zip67 repressed transcription mediated by an array of NRs. The expression data also demonstrated that Zip67 is present in the majority of SF-1-expressing tissues in both mice and humans (i.e. testis, adrenal, and spleen). Although this suggests a physiological connection between these factors, it will be important to determine the cellular localization of Zip67, because these tissues also consist of cells that do not express SF-1. In the adrenal, only the cortical part expresses SF-1 (71) . We found the expression of Zip67 in Y1 cells, which are derived from the adrenal cortex, suggesting a functional correlation between these two proteins in this tissue. In testis and spleen, SF-1-expressing cells are minor constituents (i.e. the Sertoli and Leydig cells of the testis and the red pulp of the spleen) (16, 72) , and the relatively high levels of Zip67 observed in these tissues could possibly indicate that it is expressed in other cell types as well. Experiments are underway to determine the cellular localization of Zip67 in SF-1-expressing tissues as well as in other organs.
Numerous studies have established the presence of steroidogenic enzymes in the brain and de novo steroidogenesis from cholesterol. Neurosteroids are believed to exert both genomic and nongenomic effects and to influence multiple brain functions (reviewed in Ref. 73 ). The expression data presented in Fig. 5 indicate relatively high levels of Zip67 in certain parts of the human brain (i.e. cerebellum, temporal lobe, and hippocampus), and intriguingly, these brain areas have been demonstrated to express several genes encoding steroidogenic enzymes (73) . It is especially interesting to note that among the genes expressed are CYP11A1 and CYP17, which both contain SF-1 bind- A, Expression plasmids encoding SF-1 (pCMV-SF-1; 100 ng), Zip67 (pCMV-BK-Zip67; 10-1000 ng), and GRIP1 (pSG5-HA-GRIP1; 10-1000 ng) were cotransfected with the reporter plasmid 4CRS2-luc (1.5 g) into COS-1 cells. After 48 h, the cells were harvested, and luciferase activities were determined. The figure shows the mean (ϮSD) luciferase activity from representative experiments. B, [
35 S]Methionine-labeled in vitro translated GRIP1 (3 l) and increasing amounts of Zip67 (1, 3, or 10 l) was incubated with a (His) 6 -SF-1 fusion protein (5 g). The protein mixtures or [
35 S]methionine-labeled GRIP1 (3 l) alone were then incubated with Ni-NTA agarose. After extensive washing, the proteins were analyzed by SDS-PAGE (6%). The experiment was repeated five times with equal results.
ing promoter elements that were affected by Zip67 in transient transfection experiments (Fig. 6) . Importantly, Northern blot analyses of the human central nervous system have also revealed low levels of SF-1 expression at these sites, among other areas (72) . These expression data might therefore indicate a role for Zip67 in the biosynthesis of neurosteroids. NRs are known to regulate a number of important functions in the brain, and interestingly, all of the NRs that we found to be modulated by Zip67 in transfection experiments are found at Zip67-expressing sites in the brain [i.e. ER (74) , GR (75), NGFI-B (76), PPAR (77) , and LXR (78, 79) ]. Clearly, therefore, Zip67 might exert multiple functional roles in the brain through NRs other than SF-1. We did not examine the expression of Zip67 in mouse brain, and according to existing literature, SF-1 appears to be limited to the VMH in the mouse brain (71, 80) . A recent study demonstrates a physiological role for SF-1 in energy homeostasis (81) , but definitive targets genes for SF-1 in the VMH have yet to be identified. It will be of great interest to determine whether Zip67 is expressed and affects the function of SF-1 in the VMH.
In conclusion, we have cloned and characterized a novel coregulator that represses transcription mediated by several NRs. Although we have found that Zip67 acts as a repressor on the investigated NR target promoters, further experiments are necessary to understand the full biological significance of Zip67. Interestingly, the interaction between Zip67 and the AF-2 domain might be of a novel type, as it does not appear to require NR or CoRNR boxes. We propose that the repressive properties of Zip67 are due to inhibition of coactivator recruitment. Possibly important, Zip67 possesses an intrinsic activation function when linked to GAL4, and this may imply that Zip67 can act as a transcriptional activator of still unknown promoters or in cellular contexts depleted of p160 coactivators.
MATERIALS AND METHODS
Plasmid Constructs
The expression plasmid pCMV5-SF-1 and the luciferase reporter plasmid pT81-4CRS2-luc, containing the SF-1-binding site from the proximal promoter region of the bovine CYP17 gene, were described previously (7) . The bovine CYP17Ϫ290/ϩ17 promoter fragment is inserted into the reporter pGL3-luc (pGL3-CYP17Ϫ290-luc) and was a gift from Dr. M. Waterman (Nashville, TN). The CYP11A reporter plasmid (pGL3-CYP11AϪ186-luc) contains the region between Ϫ186 and ϩ12 of the bovine CYP11A gene (49) . pHybLex/ Zeo-SF-1 107-461 contains amino acids 107-461 of the bovine SF-1 cDNA linked to the LexA DNA-binding domain in the vector pHybLex/Zeo (26) . pHybLex/Zeo-SF-1⌬AF-2 contains a 25-amino acid carboxyl-terminal deletion mutation (26) . pHybLex/Zeo-Lamin (Invitrogen, Carlsbad, CA) was used as a negative control in the interaction studies. The pYESTrpZip67 plasmid was isolated from the human testis cDNA library in the yeast two-hybrid screen, and this fragment contains 763 bp (bp 1123-1871 of the final Zip67 cDNA) inserted into the BstXI site of the pYESTrp2 vector. The expression plasmid pBK-CMV-Zip67 contains the full-length human Zip67 cDNA inserted into the ZAP Express EcoRI/ XhoI vector pBK-CMV (Stratagene, La Jolla, CA). pSG5-HA-GRIP1 and pM.GRIP1 (GAL4-GRIP1 fusion) were provided by Dr. M. Stallcup (Los Angeles, CA). pSGluc (contains GAL4-binding elements) and pBIND were obtained from Promega (Madison, WI). Zip67 was cloned in-frame with the GAL4 DNA-binding domain in the pBIND vector (pBIND-Zip67). The PPREx3-tk-luc (3PPRE-luc) reporter construct containing three copies of the peroxisome proliferate response element from the acyl-coenzyme A promoter and the expression plasmid pcDNA3.1-hPPAR␥1 were provided by Dr. K. Kristiansen (Odense, Denmark) (82) . The pGL3basic-LXR␣ (Ϫ1515/ ϩ1822)-luc (LXR␣-luc), mouse mammary tumor virus-luc, the estrogen response element-TATA-luc reporter constructs, and the expression plasmids pCMV-retinoid X receptor ␣ (RXR␣), pCMX-LXR␣, pCMV5-GR, and pSG5-ER␣ were provided by Dr. H. I. Nebb (Oslo, Norway) (83) . The NBRE-luc reporter construct contains three copies of the NGFI-B response element. The NGFI-B expression plasmid (pCMX-NGFI-B) was provided by Dr. T. Perlmann (Stockholm, Sweden). The pCMV5-C␣ plasmid expressing the catalytic subunit of PKA was a gift from Dr. G. S. McKnight (Seattle, WA). The luciferase reporter plasmid pT81-4CRE-luc were constructed as previously described for 4CRS2-luc (7). The reporter construct carrying the xenobiotic response elements (pT81-2XRE-luc) was described previously (84) .
Cloning of Zip67 cDNA
The yeast two-hybrid screen was performed according to the users manual for the LexA-based system Hybrid Hunter (Invitrogen) using a cDNA library from human testis cloned into the BstXI site of the pYESTrp2 vector (Invitrogen). The bait plasmid (pHybLex/Zeo-SF-1 ) and the cDNA library were sequentially transformed into the yeast strain EGY191 (MAT␣ ura3 trp1 his3::2lexAop-LEU2; gift from Dr. E. Golemis, Philadelphia, PA) and plated on medium containing zeocin (200 mg/ml) and lacking the selection markers leucine and tryptophan. The yeast strains that were provided with the Hybrid Hunter kit [EGY48 (MAT␣ ura3 trp1 his3(6lexAop-LEU2) GAL4) and L40 (MATa his3⌬200 trp1-901 leu2-3112 ade2 LYS2::(4lexAop-HIS3) URA3:: (8lexAop-lacZ) GAL4)] contain six or four copies of the LexA operon in front of the selection markers. Due to the intrinsic transcriptional activity of the C-terminal part of SF-1 we observed relatively high background activity in these strains. Instead, we therefore used the EGY191 strain, which contains only two copies of the LexA operon, and the background activity was reduced to a minimum. Surviving clones were replated several times, and clones that remained positive were grown in liquid medium to retrieve the cDNAs that interacted with the SF-1 bait plasmid. Yeast plasmid preparations were performed according to standard procedures. Full-length Zip67 cDNA was isolated through conventional hybridization to a human testis cDNA library using the ZAP Express system (Stratagene). However, comparison of the isolated Zip67 cDNA with the predicted cDNA from the NIX database revealed that the most 5Ј 27 nucleotides were not included in the fragment from the ZAP library. Based on the predicted cDNA, an extended oligonucleotide and an internal primer were used to generate the remaining cDNA sequence using Advantage 2 polymerase (Clontech). PCR was performed in the presence of 1% dimethylsulfoxide to reduce secondary structures. The amplified fragment was cloned in-frame with the rest of the cDNA in the pBK-CMV vector. The primers used were: forward, 5Ј-GGG-GGG-ATG-GCG-GAG-CGG-GCG-CTA-GAG-CCC-GAG-GCG-GAG-GCG-GAG-GCT-GAG-GCG-GGC-G-CG-GGC-GGG-GAG-GCA-GCA-GCC-GAG-GAG-GGC-GC-A-GCG-GGC-CGA-AAG-GCG-CGG-GGC-CGG-CC-Ј3; and reverse, 5Ј-CCG-CCG-CAG-GTG-GTT-GGA-TAA-ATA-G-Ј3. Three recent submissions to the sequence database have confirmed the predicted cDNA sequence upon which we based our approach. Based on the human Zip67 cDNA we identified sequences in the mouse expressed sequence tag database that corresponded to the 5Јand 3Ј ends of the mouse Zip67 cDNA. The full-length mouse cDNA was subsequently amplified from a testis cDNA library (Clontech) using the following primers: forward, 5Ј-AAC-TTG-CCG-CCT-ACC-TCA-TT-Ј3; and reverse, 5Ј-CCA-CTG-CCC-ACT-TTG-TCA-CT-Ј3.
In Vivo Protein Interaction Assay
A two-hybrid mating assay was used to measure the interaction between the LexA fusion bait proteins SF-1 107-461 , SF-1 107-461 ⌬AF-2 and lamin (negative control) and the B42 fusion prey protein Zip67. The LexA fusion proteins were introduced into the EGY191 strain and selected on plates containing zeocin (200 mg/ml), whereas the B42-fusion proteins were transformed into the L40 strain and selected on plates lacking tryptophan. Selection for the presence of both bait and prey plasmids (mating colonies) was carried out on plates with zeocin, lacking tryptophan. To examine the ␤-galactosidase activities, strain EGY191 was also cotransformed with the 2lexAop-lacZ reporter plasmid pJK103. (The strains EGY191 and pJK103 were provided by Dr. E. Golemis, Philadelphia, PA.) The chemiluminescent reporter gene assay system from Galacto-Star (Tropix, Bedford MA) was used to detect ␤-galactosidase activity in yeast cell extracts.
In Vitro Protein Interaction Assay
The Bac-to-Bac Baculovirus Expression System (Invitrogen) was used to express the (His) 6 -containing wild-type SF-1 fusion protein and the (His) 6 -containing SF-1⌬AF-2 with an AF-2 core (LLIEML) deletion as previously described (26) . The expressed (His) 6 -SF-1 and (His) 6 -SF-1⌬AF-2 proteins were purified using affinity chromatography with Ni-NTA agarose (Qiagen, Chatsworth, CA). [ 35 S]Methionine-labeled Zip67 was prepared using the TNT-coupled reticulocyte lysate system (Promega) in the presence of [ 35 S]methionine. For protein interaction assays, the [
35 S]methionine-labeled in vitro translated Zip67 (3 l) was incubated with purified (His) 6 -SF-1 or (His) 6 -SF-1⌬AF-2 (5 g) at 30 C for 1 h with occasional gentle mixing. The protein mixtures or the [
35 S]methionine-labeled coactivators (3 l) alone were then incubated with Ni-NTA agarose (30 l) in 20 mM Tris-HCl (pH 7.5), 50 mM KCl, 10% glycerol, 20 mM imidazole, 0.5% Nonidet P-40, 1 mM phenylmethylsulfonylfluoride, and 5 g/ml aprotinin to a total volume of 300 l on rotating wheel at room temperature for 1 h. After incubation, the Ni-NTA agarose beads were washed with 500 l of the above buffer. The Ni-NTA agarose beads were subsequently boiled for 5 min in the presence of 15 l sodium dodecyl sulfate loading buffer [100 mM Tris-HCl (pH 6.8), 100 mM dithiothreitol, 4% sodium dodecyl sulfate, 0.2% bromophenol blue, and 20% glycerol] and subjected to 6% SDS-PAGE, followed by autoradiography. The same method was used in the competition assay with [
35 S]methionine-labeled, in vitro-translated GRIP1 (3 l) and increasing amounts of [ 35 S]methionine-labeled, in vitro-translated Zip67 (1, 3, and 10 l).
Quantitative Real-Time RT-PCR
Mouse tissues were homogenized, and mRNA from the different tissues was isolated using MagNA Pure LC mRNA Isolation Kit II and MagNA Pure LC according to the manufacturer's protocol (Roche, Indianapolis, IN). Quantitative real-time RT-PCR was carried out using a LightCycler rapid thermal cycler system (Roche). Forward and reverse PCR primers designed from the mouse Zip67 sequence were as follows: forward, 5Ј-CCA-CTG-CCC-ACT-TTG-TCA-CT-3Ј; and reverse, 5Ј-AAC-TTG-CCG-CCT-ACC-TCA-TT-3Ј. The predicted size of the Zip67 PCR product was 300 bp. Forward and reverse GAPDH primers were: forward, 5Ј-ACC-ACA-GTC-CAT-GCC-ATC-AC-3Ј; and reverse, 5Ј-TCC-ACC-ACC-CTG-TTG-CTG-TA-3Ј. The predicted size of the GAPDH PCR product was 480 bp. Reactions were performed using the LightCycler RNA Master SYBR-Green I Kit (Roche), and the PCR products were detected via intercalation of the fluorescent dye SYBR-Green. Zip67 and GAPDH standards were prepared by 10-fold serial dilutions of linearized pCR2.1-mZip67 plasmid and DNA fragments containing the full-length GAPDH cDNA sequence, respectively. Standards were used over the range of 100 pg/l to 0.01 pg/l. The negative controls were prepared by replacing the mRNA template with PCR-grade H 2 O. The protocols included a 20-min RT step at 61 C, a 5-sec denaturation step, and then 45 cycles consisting of denaturation at 95 C for 5 sec, annealing at 60 C (for both Zip67 and GAPDH) for 5 sec, and an extension phase at 72 C for 18 sec (Zip67) or 20 sec (GAPDH). Fluorescence was measured at the end of the 72 C extension phase. The quality of the RT-PCR products was controlled by melting point curve analysis. In addition, the amplification products were subjected to agarose gel electrophoresis (1.6%) and stained with ethidium bromide (0.5 g/ml) to ensure specificity of amplification.
Human Multiple Tissue Array
A human multiple tissue expression array (Clontech) was probed with 32 P-labeled human Zip67 cDNA according to the manufacturer's protocol. The hybridization signals were quantified using a phosphorimager analyzer (Bas-5000, Fuji Photo Film Co., Ltd., Tokyo, Japan).
Cell Culture and Transfections
Y1 mouse adrenocortical tumor cells and HeLa cells were cultured in DMEM supplemented with 10% fetal calf serum, 100 U penicillin/ml, and 100 g streptomycin/ml. For transfection experiments, Y1 cells were plated at a density of 2.5 ϫ 10 5 cells/well onto six-well plates and transiently transfected the following day by using the calcium phosphate method according to standard procedures. Y1 cells were transfected with reporter plasmid (pT81-4CRS2-luc, pGL3-CYP17Ϫ290-luc, or pGL-CYP11AϪ186-luc; 1.5 g), pCMV-SF-1 (100 ng), and pBK-CMV-Zip67 (100-500 ng) as indicated in the figures. COS-1 and HeLa cells were seeded as described for Y1 cells, and transiently transfected the following day by the SuperFect transfection procedure according to the manufacturer's protocol (Qiagen). In the control experiments, plasmids encoding other NRs, such as pcDNA3.1-hPPAR␥1 (0.15 g), pCMV-RXR␣ (0.15 g), pCMX-LXR␣ (0.15 g), pCMX-NGFI-B (0.1 g), pCMV5-GR (0.15 g), and pSG5-ER (0.15 g), were transfected into COS-1 cells together with their respective reporters and in the presence of respective ligands as indicated in the figure. The total amount of plasmid was kept constant by compensating with empty expression vector (pCMV5). To control for transfection efficiency, an expression plasmid encoding ␤-galactosidase (pCMV-lacZ) was included in the transfection experiments. The cells were washed once with PBS 24 h (Y1) or 48 h (COS-1) after transfection, and assayed for luciferase activity. Forty microliters of the cell extracts were used for luciferase determination on a LUCY-1 luminometer (Anthos, Wals, Austria). The luciferase assay was performed in accordance with the protocol of the Luciferase Assay Kit (BIO Thema AB, Dalarö , Sweden). All transfections were performed in triplicate and repeated three to five times.
